Federation Des Caisses Desjardins Du Quebec In Med Pharmaceuticals Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in In Med Pharmaceuticals Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 19 shares of INM stock, worth $88. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19Holding current value
$88% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding INM
# of Institutions
16Shares Held
1.14MCall Options Held
0Put Options Held
0-
Advisor Shares Investments LLC Bethesda, MD733KShares$3.42 Million0.03% of portfolio
-
Ubs Group Ag212KShares$988,1010.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il56.7KShares$264,0630.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny50.3KShares$234,3790.0% of portfolio
-
Hrt Financial LP New York, NY38.4KShares$178,7990.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $4.23M
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...